Free Trial

ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Update

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totalling 908,900 shares, an increase of 25.9% from the April 15th total of 722,000 shares. Based on an average daily volume of 639,800 shares, the days-to-cover ratio is currently 1.4 days. Approximately 4.0% of the shares of the company are short sold.

Insider Activity at ASP Isotopes

In other ASP Isotopes news, Director Robert John Andrew Ryan purchased 9,500 shares of the company's stock in a transaction on Thursday, April 25th. The shares were purchased at an average cost of $3.42 per share, for a total transaction of $32,490.00. Following the completion of the transaction, the director now owns 546,555 shares in the company, valued at $1,869,218.10. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 26.30% of the company's stock.

Institutional Trading of ASP Isotopes

Institutional investors and hedge funds have recently bought and sold shares of the stock. HTLF Bank acquired a new stake in ASP Isotopes during the 4th quarter worth about $141,000. Rathbones Group PLC acquired a new stake in ASP Isotopes during the 4th quarter worth about $272,000. Finally, Vanguard Group Inc. increased its holdings in shares of ASP Isotopes by 479.1% in the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company's stock valued at $4,217,000 after purchasing an additional 844,705 shares during the period. Institutional investors and hedge funds own 16.80% of the company's stock.

Wall Street Analyst Weigh In


Separately, HC Wainwright boosted their price target on shares of ASP Isotopes from $5.25 to $5.50 and gave the stock a "buy" rating in a research report on Wednesday, April 17th.

Check Out Our Latest Stock Report on ASP Isotopes

ASP Isotopes Trading Up 4.4 %

ASPI traded up $0.16 during trading on Monday, reaching $3.76. The company had a trading volume of 352,955 shares, compared to its average volume of 577,986. The firm's 50-day simple moving average is $3.71 and its 200 day simple moving average is $2.69. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.85 and a current ratio of 1.85. The company has a market cap of $183.94 million, a price-to-earnings ratio of -7.67 and a beta of 5.15. ASP Isotopes has a 12-month low of $0.28 and a 12-month high of $4.97.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last posted its quarterly earnings data on Wednesday, April 10th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.43 million during the quarter. Equities research analysts anticipate that ASP Isotopes will post -0.11 earnings per share for the current year.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in ASP Isotopes right now?

Before you consider ASP Isotopes, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.

While ASP Isotopes currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: